Harmony Biosciences Holdings, Inc. (HRMY) vs Novavax, Inc. (NVAX)
- Harmony Biosciences Holdings, Inc. HRMY 38.20 −0.18%
- Novavax, Inc. NVAX 11.26 −12.17%
Harmony Biosciences Holdings, Inc. and Novavax, Inc. are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and Novavax, Inc. are of similar size ($2.2B and $2.1B). Novavax, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 12.2×. Harmony Biosciences Holdings, Inc. grew revenue faster over the last twelve months: 24.3% against −61.6%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.9% vs −59.9%) and the higher return on invested capital (29.7% vs 0.00%). Across the 17 metrics below, Harmony Biosciences Holdings, Inc. leads on 13 and Novavax, Inc. on 4.
Valuation
Profitability
| Metric | HRMY | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.42% | 78.60% | 65.16% |
| Operating margin | 24.03% | (56.58%) | 0.00% |
| Net margin | 18.88% | (59.87%) | 0.00% |
| Free cash flow margin | 36.99% | (10.20%) | 0.00% |
| Return on equity | 20.46% | 323.66% | (56.36%) |
| Return on assets | 14.61% | (21.62%) | (48.04%) |
| Return on invested capital | 29.70% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack